[Prevalence of hepatitis C virus antibody in chronic HBsAg-negative non alcoholic hepatopathy]

R Bárcena Marugán1, R Nash, J M Pascasio

  • 1Servicio de Gastroenterología y de Microbiología del Hospital Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá.

Insights

Antibody to hepatitis C virus (HCV) was found in 76.6% of patients with non-alcoholic chronic hepatitis. Blood transfusion recipients showed a higher prevalence of anti-HCV, suggesting HCV

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Non-alcoholic chronic hepatitis represents a significant clinical challenge.
  • Distinguishing between different viral etiologies is crucial for patient management.
  • Hepatitis C virus (HCV) infection is a major cause of chronic liver disease.

Purpose:

  • To determine the prevalence of antibody to hepatitis C virus (anti-HCV) in patients with non-alcoholic chronic hepatitis.
  • To investigate potential risk factors associated with anti-HCV positivity in this cohort.
  • To assess the role of HCV in non-alcoholic chronic hepatitis cases.

Summary:

  • Antibody to hepatitis C virus (anti-HCV) was detected in 76.6% of 316 HBsAg-negative patients with non-alcoholic chronic hepatitis.
  • A higher prevalence of anti-HCV was observed in patients with a history of blood transfusion (87.4%) compared to other risk groups.
  • The incidence of anti-HCV was lower in cirrhotics (70.3%) than in active chronic hepatitis (84.1%), with a higher transfusion history in the latter group.

Impact:

  • These findings suggest that hepatitis C virus infection is a significant contributor to non-alcoholic chronic hepatitis.
  • Highlights the importance of screening for anti-HCV in patients with chronic hepatitis of unknown etiology.
  • Informs clinical practice regarding the etiological diagnosis and management of chronic liver disease.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...